Patents by Inventor Bhanu Rajput

Bhanu Rajput has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human slit polypeptide and polynucleotides encoding same
    Publication number: 20020123104
    Abstract: This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptides of the present invention are human slit polypeptides. The invention also relates to identifying mesenchymal stem cells (MSCs) or other cells comprising such polypeptides or polynucleotides that encode the polypeptides.
    Type: Application
    Filed: December 3, 2001
    Publication date: September 5, 2002
    Inventors: Timothy Connolly, Bhanu Rajput
  • Human slit polypeptide and polynucleotides encoding same
    Patent number: 6342370
    Abstract: This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptides of the present invention are human slit polypeptides. The invention also relates to identifying mesenchymal stem cells (MSCs) or other cells comprising such polypeptides or polynucleotides that encode the polypeptides.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: January 29, 2002
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Timothy Connolly, Bhanu Rajput
  • Hybrid plasminogen activator
    Patent number: 5580559
    Abstract: Novel single-chain hybrid plasminogen activators having an amino acid sequence composed of at least two subsequences corresponding in amino acid identity and number to subsequences of human t-PA and of human u-PA, and mutants thereof in which at least one of the N-glycosylation sites is modified such that glycosylation cannot take place at these sites exhibit valuable pharmacological properties. The hybrid plasminogen activators are produced by recombinant DNA technology.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: December 3, 1996
    Assignee: Ciba-Geigy Corporation
    Inventors: Bhanu Rajput, Bhabatosh Chaudhuri, Fredericus A. M. Asselbergs, Bernd Meyhack, Jutta Heim, Jan van Oostrum, Sefik Alkan
  • DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
    Patent number: 5242819
    Abstract: Novel single-chain hybrid plasminogen activators having an amino acid sequence composed of at least two subsequences corresponding in amino acid identity and number to subsequences of human t-PA and of human u-PA, and mutants thereof in which at least one of the N-glycosylation sites is modified such that glycosylation cannot take place at these sites exhibit valuable pharmacological properties. The hybrid plasminogen activators are produced by recombinant DNA technology.
    Type: Grant
    Filed: December 13, 1991
    Date of Patent: September 7, 1993
    Assignee: Ciba-Geigy Corporation
    Inventors: Bhanu Rajput, Bhabatosh Chaudhuri, Fredericus A. M. Asselbergs, Bernd Meyhack, Jutta Heim, Jan van Oostrum, Sefik Alkan